Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

Timothy Simeone, Kristina A. Simeone, Carl E. Stafstrom, Jong M. Rho

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Although the mechanisms underlying the anti-seizure effects of the high-fat ketogenic diet (KD) remain unclear, a long-standing question has been whether ketone bodies (i.e., β-hydroxybutyrate, acetoacetate and acetone), either alone or in combination, contribute mechanistically. The traditional belief has been that while ketone bodies reflect enhanced fatty acid oxidation and a general shift toward intermediary metabolism, they are not likely to be the key mediators of the KD's clinical effects, as blood levels of β-hydroxybutyrate do not correlate consistently with improved seizure control. Against this unresolved backdrop, new data support ketone bodies as having anti-seizure actions. Specifically, β-hydroxybutyrate has been shown to interact with multiple novel molecular targets such as histone deacetylases, hydroxycarboxylic acid receptors on immune cells, and the NLRP3 inflammasome. Clearly, as a diet-based therapy is expected to render a broad array of biochemical, molecular, and cellular changes, no single mechanism can explain how the KD works. Specific metabolic substrates or enzymes are only a few of many important factors influenced by the KD that can collectively influence brain hyperexcitability and hypersynchrony. This review summarizes recent novel experimental findings supporting the anti-seizure and neuroprotective properties of ketone bodies.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalNeuropharmacology
Volume133
DOIs
StatePublished - May 1 2018

Fingerprint

Ketogenic Diet
Ketone Bodies
Hydroxybutyrates
Seizures
Inflammasomes
Diet Therapy
Histone Deacetylases
High Fat Diet
Acetone
Fatty Acids
Acids
Brain
Enzymes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Do ketone bodies mediate the anti-seizure effects of the ketogenic diet? / Simeone, Timothy; Simeone, Kristina A.; Stafstrom, Carl E.; Rho, Jong M.

In: Neuropharmacology, Vol. 133, 01.05.2018, p. 233-241.

Research output: Contribution to journalReview article

@article{0e678c31b91f43e28aac7a496080b0ad,
title = "Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?",
abstract = "Although the mechanisms underlying the anti-seizure effects of the high-fat ketogenic diet (KD) remain unclear, a long-standing question has been whether ketone bodies (i.e., β-hydroxybutyrate, acetoacetate and acetone), either alone or in combination, contribute mechanistically. The traditional belief has been that while ketone bodies reflect enhanced fatty acid oxidation and a general shift toward intermediary metabolism, they are not likely to be the key mediators of the KD's clinical effects, as blood levels of β-hydroxybutyrate do not correlate consistently with improved seizure control. Against this unresolved backdrop, new data support ketone bodies as having anti-seizure actions. Specifically, β-hydroxybutyrate has been shown to interact with multiple novel molecular targets such as histone deacetylases, hydroxycarboxylic acid receptors on immune cells, and the NLRP3 inflammasome. Clearly, as a diet-based therapy is expected to render a broad array of biochemical, molecular, and cellular changes, no single mechanism can explain how the KD works. Specific metabolic substrates or enzymes are only a few of many important factors influenced by the KD that can collectively influence brain hyperexcitability and hypersynchrony. This review summarizes recent novel experimental findings supporting the anti-seizure and neuroprotective properties of ketone bodies.",
author = "Timothy Simeone and Simeone, {Kristina A.} and Stafstrom, {Carl E.} and Rho, {Jong M.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.neuropharm.2018.01.011",
language = "English (US)",
volume = "133",
pages = "233--241",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

AU - Simeone, Timothy

AU - Simeone, Kristina A.

AU - Stafstrom, Carl E.

AU - Rho, Jong M.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Although the mechanisms underlying the anti-seizure effects of the high-fat ketogenic diet (KD) remain unclear, a long-standing question has been whether ketone bodies (i.e., β-hydroxybutyrate, acetoacetate and acetone), either alone or in combination, contribute mechanistically. The traditional belief has been that while ketone bodies reflect enhanced fatty acid oxidation and a general shift toward intermediary metabolism, they are not likely to be the key mediators of the KD's clinical effects, as blood levels of β-hydroxybutyrate do not correlate consistently with improved seizure control. Against this unresolved backdrop, new data support ketone bodies as having anti-seizure actions. Specifically, β-hydroxybutyrate has been shown to interact with multiple novel molecular targets such as histone deacetylases, hydroxycarboxylic acid receptors on immune cells, and the NLRP3 inflammasome. Clearly, as a diet-based therapy is expected to render a broad array of biochemical, molecular, and cellular changes, no single mechanism can explain how the KD works. Specific metabolic substrates or enzymes are only a few of many important factors influenced by the KD that can collectively influence brain hyperexcitability and hypersynchrony. This review summarizes recent novel experimental findings supporting the anti-seizure and neuroprotective properties of ketone bodies.

AB - Although the mechanisms underlying the anti-seizure effects of the high-fat ketogenic diet (KD) remain unclear, a long-standing question has been whether ketone bodies (i.e., β-hydroxybutyrate, acetoacetate and acetone), either alone or in combination, contribute mechanistically. The traditional belief has been that while ketone bodies reflect enhanced fatty acid oxidation and a general shift toward intermediary metabolism, they are not likely to be the key mediators of the KD's clinical effects, as blood levels of β-hydroxybutyrate do not correlate consistently with improved seizure control. Against this unresolved backdrop, new data support ketone bodies as having anti-seizure actions. Specifically, β-hydroxybutyrate has been shown to interact with multiple novel molecular targets such as histone deacetylases, hydroxycarboxylic acid receptors on immune cells, and the NLRP3 inflammasome. Clearly, as a diet-based therapy is expected to render a broad array of biochemical, molecular, and cellular changes, no single mechanism can explain how the KD works. Specific metabolic substrates or enzymes are only a few of many important factors influenced by the KD that can collectively influence brain hyperexcitability and hypersynchrony. This review summarizes recent novel experimental findings supporting the anti-seizure and neuroprotective properties of ketone bodies.

UR - http://www.scopus.com/inward/record.url?scp=85041589409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041589409&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2018.01.011

DO - 10.1016/j.neuropharm.2018.01.011

M3 - Review article

C2 - 29325899

AN - SCOPUS:85041589409

VL - 133

SP - 233

EP - 241

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -